Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC)

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 1, 2014, Pages 200-205

  Xu, Liang ^a   Tian, Jiakai ^b   Liu, Yuhui ^a   Li, Chuanfu ^c  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

diffusion magnetic resonance imaging; lung neoplasms; lymphatic metastasis; magnetic resonance imaging; neoplasm metastasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING WITH BACKGROUND SIGNAL SUPPRESSION; EVALUATION STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPH NODE; MEDIASTINUM LYMPH NODE METASTASIS; MEDIASTINUM METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ALGORITHM; ARTIFACT; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; LUNG TUMOR; LYMPH NODE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SECONDARY; SIGNAL NOISE RATIO;

ADULT; AGED; ALGORITHMS; ARTIFACTS; CARCINOMA, NON-SMALL-CELL LUNG; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL-TO-NOISE RATIO; SUBTRACTION TECHNIQUE;

EID: 84902373600     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24343     Document Type: Article

References (23)

1. Casali C, Stefani A, Natali P, Rossi G, Morandi U,. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg 2005; 28: 33-38.
2. Takamochi K, Oh S, Suzuki K,. Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer. Thorac Cardiovasc Surg 2010; 58: 345-349.
3. Miller JD, Gorenstein LA, Patterson GA,. Staging: the key to rational management of lung cancer. Ann Thorac Surg 1992; 53: 170-178.
4. Tamura M, Oda M, Tsunezuka Y, et al. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 2004; 126: 342-346.
5. Prenzel KL, Monig SP, Sinning JM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 2003; 123: 463-467.
6. Koh DM, Collins DJ,. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-1635.
7. Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL,. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am Roentgenol 2011; 197: W384-391.
8. Youden WJ,. Index for rating diagnostic tests. Cancer 1950; 3: 32-35.
9. Sverzellati N, Wells AU, Tomassetti S, et al. Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology 2010; 254: 957-964.
10. Gonzalez-Stawinski GV, Lemaire A, Merchant F, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 126: 1900-1905.
11. Leschber G, Sperling D, Klemm W, Merk J,. Does video-mediastinoscopy improve the results of conventional mediastinoscopy? Eur J Cardiothorac Surg 2008; 33: 289-293.
12. Defranchi SA, Cassivi SD, Nichols FC, et al. N2 disease in T1 non-small cell lung cancer. Ann Thorac Surg 2009; 88: 924-928.
13. Herbrik M, Treffert J, Geiger B, et al. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. J Nucl Med 2011; 52: 1520-1525.
14. Yi CA, Lee KS, Kim BT, et al. Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. AJR Am J Roentgenol 2007; 188: 318-325.
15. Bryant AS, Cerfolio RJ, Klemm KM, Ojha B,. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg 2006; 82: 417-422; discussion 422-413.
16. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y,. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol 2008; 191: 464-470.
17. Usuda K, Zhao XT, Sagawa M, et al. Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. Ann Thorac Surg 2011; 91: 1689-1695.
18. Nomori H, Mori T, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 2008; 135: 816-822.
19. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M,. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282.
20. Takenaka D, Ohno Y, Matsumoto K, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 2009; 30: 298-308.
21. Wang N, Zhang M, Sun T, et al. A comparative study: diffusion weighted whole body imaging with background body signal suppression and hybrid positron emission computed tomography on detecting lesions in oncologic clinics. Eur J Radiol 2012; 81: 1662-1666.
22. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008; 248: 643-654.
23. Kwee TC, Takahara T, Koh DM, Nievelstein RA, Luijten PR,. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 2008; 28: 1141-1148.